*Applications will be reviewed on a rolling- basis.
Two fellowship opportunities are currently available in the Division of Microbiology, National Center for Toxicological Research (NCTR) of the U.S. Food and Drug Administration (FDA) Jefferson Laboratories Campus located in Jefferson, Arkansas.
Research efforts will include participation in multi-disciplinary efforts in a nationally recognized training program in support of the FDA’s mission and training in fundamental and applied research designed to assess the effects of FDA relevant xenobiotic compounds on the gastrointestinal tract. Through these fellowships, the selected participants will have the opportunity to learn and apply techniques to investigate in vivo, in vitro and ex vivo models of gastrointestinal tracts to assess the effects of the test compound on intestinal microbiota, intestinal permeability, gut associated immune responses, xenobiotic metabolism and antimicrobial resistance.
While contributing to the projects, the participants will be actively encouraged to present the research at internal and external conferences, as per FDA rules, and publish the findings in peer-reviewed journals.
Anticipated Appointment Start Date: February 1, 2022; start date is flexible
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Jefferson, Arkansas, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.